Drug Safety and Pharmacovigilance in Clinical Practice

Drug safety and pharmacovigilance remains a dynamic clinical and scientific discipline. Pharmacovigilance is defined by the World Health Organization (WHO) as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem"; it plays a vital role in ensuring that doctors, together with the patient, have enough information to make a decision when it comes to choosing a drug for treatment. However, despite all their benefits, evidence continues to get those bigger adverse reactions to medicines which are common, yet often preventable, cause of illness, disability and even death. In some countries, adverse drug reactions (ADRs) rank among the top 10 leading causes of mortality. In order to prevent or to reduce harm to patients and thus improve public health, mechanisms for evaluating and monitoring the safety of medicines in clinical use are vital.

Monday, 29 September, 2014 to Tuesday, 30 September, 2014
Athens, Greece
VenueEvangelismos Hospital

Registration form

Please complete with CAPITAL letters.
(fields with * are mandatory)

Please indicate your professional category